COVID-19 increases risk of developing Alzheimer's by 50-80% in older adults

  • 📰 NewsMedical
  • ⏱ Reading Time:
  • 31 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 16%
  • Publisher: 71%

United Kingdom News News

United Kingdom Latest News,United Kingdom Headlines

COVID-19 increases risk of developing Alzheimer's by 50-80% in older adults Coronavirus Disease COVID Coronavirus Healthcare Inflammation Pathophysiology IOSPress_STM CWRUSOM NIH cwru

By Pooja Toshniwal PahariaSep 18 2022Reviewed by Emily Henderson, B.Sc. In a recent study published in the Journal of Alzheimer’s Disease, researchers in the United States investigated whether severe acute respiratory syndrome coronavirus 2 infections could trigger the development of new-onset Alzheimer’s disease

About the study Researchers examined the risk of new-onset AD among SARS-CoV-2-positive patients in the present retrospective cohort study. AD and SARS-CoV-2 infection status were based on the ICD-10 codes and laboratory-based analyses. The risk of new-onset AD was examined for the two groups stratified by race and age .

Comorbid conditions such as hypertension, obesity, type II diabetes, depression, hearing loss, traumatic brain injury, tobacco smoking, and heavy alcohol consumption were prevalent among 60%, 23%, 30%, 22%, 5.8%, 3.1%,11%, and 3.8% of the sample population, respectively.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 19. in UK

United Kingdom Latest News, United Kingdom Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Alzheimer-stricken gran 'trapped' in Lanarkshire hospital as family fight to bring her homeJacqueline Clark, who suffers from Alzheimer's, has been in Hairmyres Hospital in East Kilbride for the last six months after enduring a massive stroke while recovering from Covid-19.
Source: Glasgow_Live - 🏆 4. / 97 Read more »

An improved COVID-19 vaccine shows promise against Omicron in experimental modelsIn a recent study published in the journal Science Translational Medicine, researchers in the United States designed a bivalent coronavirus disease 2019 (COVID-19) vaccine on the messenger ribonucleic acid (mRNA) platform.
Source: NewsMedical - 🏆 19. / 71 Read more »

Against expectations, covid-19 retirees are returning to workIn the second quarter, 75,000 Britons in paid work said that they had been retired the year before. This is far higher than the pre-pandemic norm—and it is a similar story in America Nice Tom Brady thumb nail Lol Tom Brady has nothing to do with this. He is not even at retiring age Ah yes, Tom Brady, the every day American worker back from Covid.
Source: TheEconomist - 🏆 6. / 92 Read more »

Lung function and radiological findings 1 year after COVID-19: a prospective follow-up - Respiratory ResearchBackground The coronavirus disease (COVID-19) pandemic has already affected more than 400 million people, with increasing numbers of survivors. These data indicate that a myriad of people may be affected by pulmonary sequelae of the infection. The aim of this study was to evaluate pulmonary sequelae in patients with bilateral COVID-19 pneumonia according to severity 1 year after hospital discharge. Methods COVID-FIBROTIC is a multicenter prospective observational cohort study for admitted patients with bilateral COVID-19 pneumonia. Pulmonary functional outcomes and chest computed tomography sequelae were analyzed 12 months after hospital discharge and we classified patients into three groups according to severity. A post hoc analysis model was designed to establish how functional test changed between groups and over time. A multivariable logistic regression model was created to study prognostic factors for lung diffusion impairment and radiological fibrotic-like changes at 12 months. Results Among 488 hospitalized patients with COVID-19 pneumonia, 284 patients had completed the entire evaluation at 12 months. Median age was 60.5 ± 11.9 and 55.3% were men. We found between-group differences in male sex, length of hospital stay, radiological involvement and inflammatory laboratory parameters. The functional evaluation of pulmonary sequelae showed that severe patients had statistically worse levels of lung diffusion at 2 months but no between group differences were found in subsequent controls. At 12-month follow up, however, we found impaired lung diffusion in 39.8% unrelated to severity. Radiological fibrotic-like changes at 12 months were reported in 22.7% of patients (102/448), only associated with radiological involvement at admission (OR: 1.55, 95% CI 1.06–2.38; p = 0.02) and LDH (OR: 0.99, 95% CI 0.98–0.99; p = 0.046). Conclusion Our data suggest that a significant percentage of individuals would develop pulmonary sequelae after COVID 19 pneumonia, regardless of
Source: BioMedCentral - 🏆 22. / 71 Read more »

Back-to-School COVID Vaccine Clinic Held in BostonFamilies lined up to get their COVID-19 vaccines at White Stadium in Boston on Saturday as children begin school for the year. Teachers and children ages 6 months and older who received the vaccine also walked away with a $75 gift card. The event, part of the Boston Public Health Commission and CIC Health’s B Healthy back to school campaign,… Free candy!!! Get in the van!!! We’re still doing this?
Source: NECN - 🏆 20. / 71 Read more »